In ovarian cancer, overexpressed STC2 promotes epithelial-mesenchymal transition, as manifested by the increase in N-cadherin/vimentin loose fibroblastic colonies and the mesenchymal marker expression, and the decrease in epithelial marker expression (Law and Wong, 2010). Here, STC2 is linked to ovarian cancer.